Since 2018, Clinique La Prairie, an international leader in longevity and well-being, has taken into consideration the importance of genetic capital and environmental factors on wellness, by integrating genetic testing into its one-week Revitalization and Master Detox programs. In keeping with its desire to constantly innovate, since February 2021 it introduced a new epigenetic assessment into its range of diagnostics and personalized medicine, to add a measure of the influence of the environment and lifestyle on gene expression.

Founded in 1931 by Professor Paul Niehans, a pioneer in longevity and cell therapy, Clinique La Prairie is the leading destination for people seeking profound changes in their health and well-being.
A new epigenetic test for Clinique La Prairie clients Since 2018, Clinique La Prairie, an international leader in longevity and well-being, has taken into consideration the importance of genetic capital and environmental factors on wellness, by integrating genetic testing into its one-week Revitalization and Master Detox programs. In keeping with its desire to constantly innovate, since February 2021 it introduced a new epigenetic assessment into its range of diagnostics and personalized medicine, to add a measure of the influence of the environment and lifestyle on gene expression.
The assessment is based on blood tests and is the result of a collaboration between Clinique La Prairie and Genknowme, a swiss company specializing in the analysis of the influence of lifestyle on genes. An analysis of DNA methylation then measures the biological age (as opposed to chronological age) and shows how quickly the body ages as a result of lifestyle choices. This unique reading promotes an accurate diagnosis and provides the clinic's doctors with all the information they need to recommend changes in nutrition, environment, anti-stress approach and sport for a healthy lifestyle adapted to each DNA profile.

Read full press release